A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy
被引:0
作者:
S. Pal
论文数: 0引用数: 0
h-index: 0
机构:Regional Movement Disorders Unit,
S. Pal
K. F. Bhattacharya
论文数: 0引用数: 0
h-index: 0
机构:Regional Movement Disorders Unit,
K. F. Bhattacharya
C. Agapito
论文数: 0引用数: 0
h-index: 0
机构:Regional Movement Disorders Unit,
C. Agapito
K. Ray Chaudhuri
论文数: 0引用数: 0
h-index: 0
机构:Regional Movement Disorders Unit,
K. Ray Chaudhuri
机构:
[1] Regional Movement Disorders Unit,
[2] King's College Hospital,undefined
[3] University Hospital of Lewisham and Guy's King's & St. Thomas' School of Medicine,undefined
Objective. To determine if therapy with an ergot and a non-ergot dopamine agonist and levodopa confers an increased risk of excessive daytime sleepiness and secondary "sleep attacks" in Parkinson's disease (PD).